Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
Authors
- Zhen Wu (ORCID: https://orcid.org/0000-0001-6936-8207)
- Wenjun Wang (ORCID: https://orcid.org/0000-0001-6882-7037)
- Liling Tan (ORCID: https://orcid.org/0000-0001-7601-903X)
- Zhijun Chen (ORCID: https://orcid.org/0009-0006-3132-2266)
- Xinlan Tang
- Yu Su
Institutions
- Nanchang University (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3389/fendo.2025.1587412
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00